Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Walter Liebeschuetz is active.

Publication


Featured researches published by John Walter Liebeschuetz.


Bioorganic & Medicinal Chemistry Letters | 2003

A four component coupling strategy for the synthesis of d-phenylglycinamide-derived non-covalent factor Xa inhibitors

Scott Martin Sheehan; John Joseph Masters; Michael Robert Wiley; Stephen Young; John Walter Liebeschuetz; Stuart Donald Jones; Christopher W. Murray; Jeffrey B. Franciskovich; David Birenbaum Engel; Wayne W. Weber; Jothirajah Marimuthu; Jeffrey Alan Kyle; Jeffrey K. Smallwood; Mark W. Farmen; Gerald F. Smith

A novel isonitrile derivative was synthesized and used in an Ugi four component coupling reaction to explore aryl group substitution effects on inhibition of the coagulation cascade serine protease factor Xa.


Bioorganic & Medicinal Chemistry Letters | 2001

The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa

Stuart Donald Jones; John Walter Liebeschuetz; Phillip John Morgan; Christopher W. Murray; Andrew David Rimmer; Jonathan Michael Ernest Roscoe; Bohdan Waszkowycz; Pauline Mary Welsh; William Alexander Wylie; Stephen Clinton Young; Harry Martin; Jacqui Mahler; Leo Brady; Kay Wilkinson

Factor Xa, a critical serine protease in the blood coagulation cascade, has become a target for inhibition as a strategy for the invention of novel anti-thrombotic agents. Here we describe the development of phenylglycine containing benzamidine carboxamides as novel, potent and selective inhibitors of factor Xa.


Journal of Medicinal Chemistry | 2002

Pro_Select: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors

John Walter Liebeschuetz; Stuart Donald Jones; Phillip John Morgan; Chris W. Murray; Andrew David Rimmer; Jonathan Michael Ernest Roscoe; Bohdan Waszkowycz; Pauline Mary Welsh; William Alexander Wylie; Stephen Young; Harry Martin; Jacqui Mahler; Leo Brady; Kay Wilkinson


Archive | 1998

1-amino-7-isoquinoline derivatives as serine protease inhibitors

John Walter Liebeschuetz; William Alexander Wylie; Bohdan Waszkowycz; Christopher William Murray; Andrew David Rimmer; Pauline Mary Welsh; Stuart Donald Jones; Jonathan Michael Ernest Roscoe; Stephen Clinton Young; Phillip John Morgan; Nicholas Paul Camp; Andrew Philip Austin Crew


Archive | 2001

Meta-benzamidine derivatives as serine protease inhibitors

John Walter Liebeschuetz; William Alexander Wylie; Bohdan Waszkowycz; Christopher William Murray; Andrew David Rimmer; Pauline Mary Welsh; Stuart Donald Jones; Jonathan Michael Ernest Roscoe; Stephen Clinton Young; Phillip John Morgan


Bioorganic & Medicinal Chemistry Letters | 2007

d-Phenylglycinol-derived non-covalent factor Xa inhibitors: Effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity

Valentine J. Klimkowski; Brian Morgan Watson; Michael Robert Wiley; John Walter Liebeschuetz; Jeffry Bernard Franciskovich; Jothirajah Marimuthu; Jolie Anne Bastian; Daniel Jon Sall; Jeffrey K. Smallwood; Nikolay Y. Chirgadze; Gerald F. Smith; Ronald S. Foster; Trelia J. Craft; Philip Sipes; Marcia K. Chastain; Scott Martin Sheehan


Methods in molecular medicine | 2004

Factor Xa inhibitors.

John Walter Liebeschuetz; Scott Martin Sheehan; Brian Morgan Watson


Bioorganic & Medicinal Chemistry Letters | 2007

Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitors.

Jeffry Bernard Franciskovich; John Joseph Masters; Wayne W. Weber; Valentine J. Klimkowski; Michael L. Chouinard; Philip Sipes; Lea M. Johnson; David W. Snyder; Marcia K. Chastain; Trelia J. Craft; Richard D. Towner; Donetta S. Gifford-Moore; Larry L. Froelich; Jeffrey K. Smallwood; Ronald S. Foster; Gerald F. Smith; John Walter Liebeschuetz; Christopher William Murray; Stephen Clinton Young


Archive | 2005

Bisaryl-sulfonamide Bis-aryl sulfonamides

Philippe Bergeron; Christopher N. Farthing; Stuart Donald Jones; John Walter Liebeschuetz; Sarah E. Lively; Lawrence R. McGee; Sharon McKendry; David Sheppard; Stephen Clinton Young


Archive | 2005

DERIVADOS DE PROTEASA DE SERINA.

Nicholas Paul Camp; David Birenbaum Engel; Peter Robert Guzzo; Stuart Donald Jones; John Walter Liebeschuetz; John Joseph Masters; Michael John Mayer; Christopher William Murray; Scott Martin Sheehan; Brian Morgan Watson; Michael Robert Wiley; William Alexander Wylie; Stephen Clinton Young

Collaboration


Dive into the John Walter Liebeschuetz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge